Amgen cholesterol drug cuts heart attack, stroke risk but shares fall

Amgen Inc,'s Repatha drug cut the risk of heart attacks and strokes by over 20 percent in patients with heart disease, demonstrating a clinical benefit beyond its ability to slash "bad" LDL cholesterol levels, data from a huge study known as Fourier showed on Friday.
Source link